Freenome CPO reports stock and option holdings
Freenome, Inc. Chief Product Officer Ennis Riley Charles files an initial ownership report detailing his holdings of common stock and stock options.
Rhea-AI Filing Summary
Freenome, Inc. Chief Product Officer Ennis Riley Charles files an initial ownership report detailing his holdings of common stock and stock options. He reports direct ownership of common stock and additional shares held indirectly by the Riley Ennis Irrevocable Trust, for which he disclaims beneficial ownership except for any pecuniary interest.
The filing lists several stock options (rights to buy common stock) with exercise prices ranging from $4.8500 to $18.2400 and expirations between 2030 and 2035, including options that are fully vested and others that vest in monthly installments. One option’s exercise price will be automatically reduced to $8.45 upon certain events.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Ennis Riley Charles
Role
Chief Product Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) F2 | -- | -- | -- |
| holding | Stock Option (right to buy) F6, F2 | -- | -- | -- |
| holding | Stock Option (right to buy) F6, F3 | -- | -- | -- |
| holding | Stock Option (right to buy) F6, F4 | -- | -- | -- |
| holding | Stock Option (right to buy) F6, F5 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 1,007,337 contracts (Direct);
Common Stock — 2,490,453 shares (Direct);
Common Stock — 373,913 shares (Indirect, By Trust)
Footnotes (6)
- F1. Represents shares held by the Riley Ennis Irrevocable Trust dated 1/14/21. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- F2. The shares subject to this option are fully vested.
- F3. 25% of the shares subject to this option shall vest and become exercisable on February 2, 2024 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F4. The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from February 16, 2024, subject to the Reporting Person's continued service on each such vesting date.
- F5. 25% of the shares subject to this option shall vest and become exercisable on February 15, 2026 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F6. This option was previously amended, pursuant to which the exercise price of the option will be automatically reduced to $8.45 upon the occurrence of certain events.
Key Figures
Direct common stock holding: 2490453.0000 shares
Indirect common stock by trust: 373913.0000 shares
Option at $4.8500: 310958.0000 underlying shares
+5 more
8 metrics
Direct common stock holding
2490453.0000 shares
Common Stock directly owned as reported as of 2026-07-20
Indirect common stock by trust
373913.0000 shares
Common Stock held indirectly by the Riley Ennis Irrevocable Trust
Option at $4.8500
310958.0000 underlying shares
Stock Option (right to buy) at $4.8500 expiring 2030-06-21, fully vested
Option at $15.9100
281369.0000 underlying shares
Stock Option at $15.9100 expiring 2032-06-21; exercise price may reduce to $8.45 upon certain events
Option at $11.8800
75082.0000 underlying shares
Stock Option expiring 2033-02-17 with scheduled vesting starting February 2, 2024
Option at $18.2400
118471.0000 underlying shares
Stock Option expiring 2034-02-15 vesting in 36 equal monthly installments from February 16, 2024
Option at $14.0000
221457.0000 underlying shares
Stock Option expiring 2035-03-10 with 25% vesting on February 15, 2026 and the rest monthly
Amended reduced exercise price
$8.45
Amended exercise price to be applied automatically upon occurrence of certain events
Key Terms
Irrevocable Trust, pecuniary interest, Section 16 of the Securities Exchange Act of 1934, Stock Option (right to buy, +2 more
6 terms
Irrevocable Trust financial
"Represents shares held by the Riley Ennis Irrevocable Trust dated 1/14/21."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
pecuniary interest financial
"except to the extent of his pecuniary interest therein, if any."
Section 16 of the Securities Exchange Act of 1934 regulatory
"for purposes of Section 16 of the Securities Exchange Act of 1934, as amended"
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.
Stock Option (right to buy financial
"security_title": "Stock Option (right to buy)"
vest and become exercisable financial
"25% of the shares subject to this option shall vest and become exercisable"
exercise price financial
"the exercise price of the option will be automatically reduced to $8.45"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the vesting schedules for key options reported in this Form 3 affecting PCSC investors?
One option is fully vested. Others vest with 25% on a stated initial date and the remainder in 36 equal monthly installments, or entirely in 36 monthly installments, all conditioned on the Reporting Person’s continued service on each vesting date.
How does the automatic exercise price adjustment work in the Freenome CPO’s options disclosed for PCSC?
A reported option was previously amended so that its exercise price will be automatically reduced to $8.45 upon the occurrence of certain events. The filing notes this adjustment but does not describe those triggering events in further detail.
Does this Form 3 for PCSC show trades or just holdings for the Freenome CPO?
The entries are classified as holdings, and the transaction summary shows no reported purchases or sales. It functions as an initial snapshot of the officer’s existing common stock and stock option positions under Section 16 reporting requirements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
